By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Zealand Pharma A/S  

Smedeland 26 B

Glostrup    DK-2600  Denmark
Phone: 45-43-28-12-00 Fax: 45-43-28-12-12


Company News
Zealand Pharma  (ZEAL.CO) Release: Phase IIa Trial Results Support Development Of Dasiglucagon In The ILet Pump System For Type 1 Diabetes 6/22/2017 11:14:59 AM
Zealand Pharma  (ZEAL.CO) Release: Glepaglutide Meets Primary Endpoint In Phase II Trial In Patients With Short Bowel Syndrome 6/19/2017 10:46:11 AM
Zealand Pharma  (ZEAL.CO) - Admittance To Trading And Official Listing Of New Shares Due To Exercise Of Employee Warrants 6/15/2017 8:17:39 AM
Zealand Pharma  (ZEAL.CO) Release: New Analysis Shows Soliqua 100/33 Lowered HbA1c By More Than 2% In Patients With Screening Levels Greater Than 9% 6/12/2017 1:11:39 PM
Helsinn Passes On Zealand Pharma  (ZEAL.CO)'s Chemotherapy-Induced Diarrhea Med 6/12/2017 6:46:02 AM
Total Number Of Shares And Voting Rights In Zealand Pharma  (ZEAL.CO) At May 31, 2017 5/31/2017 10:13:46 AM
Zealand Pharma  (ZEAL.CO) Increases Its Share Capital As A Consequence Of Exercise Of Employee Warrants 5/30/2017 11:19:02 AM
Zealand Pharma  (ZEAL.CO) Release: Positive Phase IIa Results With Microdoses Of Dasiglucagon Support Use In A Dual-Hormone Artificial Pancreas System 5/23/2017 11:24:42 AM
Zealand Pharma  (ZEAL.CO) Reports Results For The First Three Months Of 2017 (Unaudited) 5/17/2017 10:45:43 AM
Zealand Pharma  (ZEAL.CO) Discloses Amylin As The Biological Target Under Their 2014 Agreement With Boehringer Ingelheim 5/11/2017 11:33:08 AM